Toggle Main Menu Toggle Search

Open Access padlockePrints

COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy

Lookup NU author(s): Jamie Leighton, Professor Robert TaylorORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© The Author(s) 2026.Primary mitochondrial diseases (PMDs) affect approximately 1 in 4300 individuals and cause early-onset neuromuscular and multisystem dysfunction with reduced lifespan. They result from pathogenic variants in mitochondrial or nuclear DNA that impair oxidative phosphorylation. Cytochrome c oxidase (COX; complex IV) deficiency is a well-established cause of PMD, leading to a broad spectrum of phenotypes. COXFA4 (cytochrome c oxidase subunit FA4), formerly NDUFA4, is a nuclear-encoded COX subunit, but its role in disease remains poorly defined. We report the largest genetically confirmed cohort of COXFA4-related PMD to date, comprising 13 individuals from 12 families with biallelic pathogenic COXFA4 variants. All present with Leigh-like encephalopathy and complete loss of COXFA4 protein; however, patient-derived fibroblasts retain residual COX activity, with upregulation of COXFA4L2 (cytochrome c oxidase subunit FA4-like 2), a poorly characterised paralog. Here, we show that COXFA4 is a late-stage COX assembly subunit and identify a paralog-mediated compensatory mechanism with translational potential.


Publication metadata

Author(s): Falabella M, Lopez Calcerrada S, Aref J, Gao J, Macken WL, Pizzamiglio C, Kabiljo R, Francavilla AL, Gaignard P, Pouzet A, Levy J, Barcia G, Leighton JK, Chronopoulou E, Pierre G, Koksal Ozgul R, Dursun A, Halligan R, Mundy H, Raza Alvi J, Sultan T, Craigen WJ, Emrick L, Rosenfeld JA, Elmakkawy G, Kim J, Gleeson JJ, Rad A, Oprea G, Hussain M, Rehman KU, Riaz S, Taylor RW, Procaccio V, Zaki MS, Fernandez-Vizarra E, Pierri CL, Hanna MG, Houlden H, Maroofian R, Ugalde C, Taanman J-W, Pitceathly RDS

Publication type: Article

Publication status: Published

Journal: Nature Communications

Year: 2026

Volume: 17

Online publication date: 30/05/2026

Acceptance date: 27/04/2026

Date deposited: 04/08/2026

ISSN (electronic): 2041-1723

Publisher: Nature Research

URL: https://doi.org/10.1038/s41467-026-73455-9

DOI: 10.1038/s41467-026-73455-9

Data Access Statement: The authors confirm that the data supporting the findings of this study are available within the article and/or its Supplementary Information. Source data for all immunoblots are provided with the paper. [More at https://www.nature.com/articles/s41467-026-73455-9#data-availability ]

PubMed id: 42218136


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
LifeArc Centre to Treat Mitochondrial Diseases (G125217)
Lily Foundation
the Pathological Society
UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of Adults and Children
UK NIHR Biomedical Research Centre for Ageing and Age-related disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust
UKRI Medical Research Council strategic award (MR/S005021/1)
Wellcome Centre for Mitochondrial Research (203105/Z/16/Z)

Share